Early research (Phase 1)Study completedNCT04932824
What this trial is testing
Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.
Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 137